UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000031822 |
|---|---|
| Receipt number | R000036343 |
| Scientific Title | Neoadjuvant nab-paclitaxel plus gemcitabine therapy for resectable pancreatic cancer; A phase II multicenter trial |
| Date of disclosure of the study information | 2018/03/20 |
| Last modified on | 2022/09/27 09:35:37 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/03/20 21:51:38 | ||
| 2 | Update | 2022/09/27 09:28:59 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Zip code Address Last name of contact person Last name of contact person Zip code Address Institute Organization Organization Address Address Tel |
|
| 3 | Update | 2022/09/27 09:35:37 | Recruitment status Date of IRB Last follow-up date |
